![](https://investingnews.com/media-library/radiopharm-theranostics.png?id=52476791&width=1200&height=600&coordinates=0%2C75%2C0%2C75)
Investor Webinar – 3pm AEST Tuesday 2 July
Radiopharmaceutical industry leader, Lantheus Holdings, Inc., has agreed to make an initial strategic equity investment of A$7.5m at A$0.05 per share, which represents a 47% premium to last closing price of A$0.034 on 19 June 2024 Two Tranche Placement to …